Literature DB >> 19386559

Sulfenic acid--a key intermediate in albumin thiol oxidation.

Lucía Turell1, Horacio Botti, Sebastián Carballal, Rafael Radi, Beatriz Alvarez.   

Abstract

The single thiol of human serum albumin (HSA-SH) is the predominant plasma thiol. Both circulating albumin and pharmaceutical preparations are heterogeneous regarding the thiol redox status, as revealed by anion-exchange-hydrophobic interaction chromatography. Sulfenic acid (HSA-SOH) is an intermediate in HSA-SH oxidation processes that was detected through different techniques including mass spectrometry. Recently, quantitative data led to the determination of rate constants. The preferred fate of HSA-SOH is the formation of mixed disulfides. Alternatively, HSA-SOH can be further oxidized to sulfinic and sulfonic acids. Oxidized forms increase under disease conditions, underscoring the importance of HSA-SH as a plasma scavenger of intravascular oxidants. We here provide a critical review of the oxidation of HSA-SH in the context of the intravascular compartment, with emphasis in the methodological approaches of mass spectrometry and chromatography for the analysis of albumin thiol redox states.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386559     DOI: 10.1016/j.jchromb.2009.03.035

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  14 in total

1.  Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring.

Authors:  He Li; Hasmik Grigoryan; William E Funk; Sixin Samantha Lu; Sherri Rose; Evan R Williams; Stephen M Rappaport
Journal:  Mol Cell Proteomics       Date:  2010-12-30       Impact factor: 5.911

2.  Cys34 adducts of reactive oxygen species in human serum albumin.

Authors:  Hasmik Grigoryan; He Li; Anthony T Iavarone; Evan R Williams; Stephen M Rappaport
Journal:  Chem Res Toxicol       Date:  2012-05-31       Impact factor: 3.739

3.  HPLC separation of human serum albumin isoforms based on their isoelectric points.

Authors:  Lucía Turell; Horacio Botti; Lucía Bonilla; María José Torres; Francisco Schopfer; Bruce A Freeman; Larissa Armas; Alejandro Ricciardi; Beatriz Alvarez; Rafael Radi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-20       Impact factor: 3.205

4.  Modulation of the reactivity of the thiol of human serum albumin and its sulfenic derivative by fatty acids.

Authors:  María José Torres; Lucía Turell; Horacio Botti; Laura Antmann; Sebastián Carballal; Gerardo Ferrer-Sueta; Rafael Radi; Beatriz Alvarez
Journal:  Arch Biochem Biophys       Date:  2012-03-19       Impact factor: 4.013

Review 5.  The thiol pool in human plasma: the central contribution of albumin to redox processes.

Authors:  Lucía Turell; Rafael Radi; Beatriz Alvarez
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

6.  Capturing labile sulfenamide and sulfinamide serum albumin adducts of carcinogenic arylamines by chemical oxidation.

Authors:  Lijuan Peng; Robert J Turesky
Journal:  Anal Chem       Date:  2012-12-28       Impact factor: 6.986

7.  Possibilities and pitfalls in quantifying the extent of cysteine sulfenic acid modification of specific proteins within complex biofluids.

Authors:  Douglas S Rehder; Chad R Borges
Journal:  BMC Biochem       Date:  2010-07-01       Impact factor: 4.059

8.  Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.

Authors:  Chad R Borges; Douglas S Rehder; Sally Jensen; Matthew R Schaab; Nisha D Sherma; Hussein Yassine; Boriana Nikolova; Christian Breburda
Journal:  Mol Cell Proteomics       Date:  2014-04-15       Impact factor: 5.911

9.  Protein Oxidative Modifications: Beneficial Roles in Disease and Health.

Authors:  Zhiyou Cai; Liang-Jun Yan
Journal:  J Biochem Pharmacol Res       Date:  2013-03

10.  Red blood cells protect albumin from cigarette smoke-induced oxidation.

Authors:  Graziano Colombo; Ranieri Rossi; Nicoletta Gagliano; Nicola Portinaro; Marco Clerici; Andrea Annibal; Daniela Giustarini; Roberto Colombo; Aldo Milzani; Isabella Dalle-Donne
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.